pyrazines has been researched along with Lassa Fever in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 8 (88.89) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Guedj, J; Lingas, G; Rosenke, K; Safronetz, D | 1 |
Akondy, RS; Cannon, D; Ellebedy, AH; Harmon, JR; Klena, JD; Kraft, CS; Lyon, MG; McElroy, AK; Mehta, AK; Nichol, ST; Ribner, BS; Sette, A; Sidney, J; Spiropoulou, CF; Varkey, JB | 1 |
Carrillo-Bustamante, P; Graw, F; Guedj, J; Günther, S; Nguyen, THT; Oestereich, L | 1 |
Becker, S; Brown, S; De Leuw, P; Eickmann, M; Faber, K; Kann, G; Klena, JD; Kraft, CS; Lyon, GM; McElroy, A; Mehta, AK; Morales, A; Nichol, S; Patel, K; Raabe, VN; Rabenau, H; Ribner, BS; Rollin, PE; Schuettfort, G; Stephan, C; Strecker, T; Ströher, U; Vanairsdale, S; Varkey, JB; Wolf, T | 1 |
Ippolito, G; Nicastri, E; Vairo, F | 1 |
Drenzek, C; Kraft, CS; O'Neal, JP; Raabe, V | 1 |
Feldmann, F; Feldmann, H; Furuta, Y; Gowen, BB; Hanley, PW; Komeno, T; Lovaglio, J; Martellaro, C; Rosenke, K; Safronetz, D; Saturday, G; Scott, DP; Westover, JB | 1 |
Feldmann, H; Furuta, Y; Geisbert, J; Geisbert, TW; Gowen, BB; Komeno, T; Martellaro, C; Okumura, A; Rosenke, K; Safronetz, D; Saturday, G; Westover, JB | 1 |
Bockholt, S; Günther, S; Krasemann, S; Lüdtke, A; Muñoz-Fontela, C; Oestereich, L; Pallasch, E; Rieger, T; Ruibal, P; Wurr, S | 1 |
1 trial(s) available for pyrazines and Lassa Fever
Article | Year |
---|---|
Use of Favipiravir to Treat Lassa Virus Infection in Macaques.
Topics: Amides; Animals; Antiviral Agents; Female; Injections, Subcutaneous; Lassa Fever; Lassa virus; Macaca; Monkey Diseases; Pyrazines; Random Allocation; Treatment Outcome | 2018 |
8 other study(ies) available for pyrazines and Lassa Fever
Article | Year |
---|---|
Lassa viral dynamics in non-human primates treated with favipiravir or ribavirin.
Topics: Amides; Animals; Antiviral Agents; Female; Host-Pathogen Interactions; Lassa Fever; Lassa virus; Macaca fascicularis; Models, Biological; Pyrazines; Ribavirin; Viral Load | 2021 |
A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses.
Topics: Adult; Amides; Antibodies, Viral; Antigens, Viral; Antiviral Agents; CD8-Positive T-Lymphocytes; Enzyme-Linked Immunosorbent Assay; Humans; Immunity, Cellular; Immunoglobulin Class Switching; Lassa Fever; Lassa virus; Lymphocyte Activation; Male; Pyrazines; Ribavirin; Viremia | 2017 |
Determining Ribavirin's mechanism of action against Lassa virus infection.
Topics: Amides; Animals; Antiviral Agents; Disease Models, Animal; Drug Therapy, Combination; Lassa Fever; Lassa virus; Mice, Inbred C57BL; Models, Theoretical; Pyrazines; Ribavirin; Treatment Outcome; Viral Load | 2017 |
Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever.
Topics: Adult; Amides; Antiviral Agents; Humans; Lassa Fever; Lassa virus; Male; Polymerase Chain Reaction; Pyrazines; Ribavirin; RNA, Viral; Togo | 2017 |
Discharge Criteria for Patient With Lassa Fever Infection.
Topics: Amides; Humans; Lassa Fever; Patient Discharge; Pyrazines; Ribavirin | 2018 |
Reply to Nicastri et al.
Topics: Amides; Humans; Lassa Fever; Pyrazines; Ribavirin | 2018 |
The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset.
Topics: Amides; Animals; Animals, Outbred Strains; Antibodies, Viral; Antiviral Agents; Drug Administration Schedule; Drug Dosage Calculations; Guinea Pigs; Humans; Immunoglobulin G; Lassa Fever; Lassa virus; Liver; Lung; Male; Pyrazines; Ribavirin; Spleen; Survival Analysis; Viral Load | 2015 |
Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever.
Topics: Amides; Animals; Antiviral Agents; Chlorocebus aethiops; Drug Therapy, Combination; Lassa Fever; Mice; Pyrazines; Ribavirin; Vero Cells; Viral Load; Virus Replication | 2016 |